MyHealthScout.com : We Provide The Best in Health Supplements for Less » MyHealthScout.com » Articles » Liver » Progen Update On Phase 3 Clinical Program For PI-88 In Liver Cancer (Medical News Tod

Progen Update On Phase 3 Clinical Program For PI-88 In Liver Cancer (Medical News Tod

Refer This Offer To a Friend

Information on Progen Update On Phase 3 Clinical Program For PI-88 In Liver Cancer (Medical News Tod under Liver section of the Health Articles & Reviews; Progen Pharmaceuticals Limited (ASX: PGL; Nasdaq: PGLA) announced that in light of the recent Fast Track designation awarded to PI-88 for the prevention of tumour ...

LinkBack

Article Tools

Display Modes

A F Boyle

Senior Member

Join Date: Sep 2007

Post a Comment

Progen Update On Phase 3 Clinical Program For PI-88 In Liver Cancer (Medical News Tod

by A F Boyle 11-04-2007, 08:58 AM

Progen Pharmaceuticals Limited (ASX: PGL; Nasdaq: PGLA) announced that in light of the recent Fast Track designation awarded to PI-88 for the prevention of tumour recurrence following curative resection of primary liver cancer and in order to commence the Phase 3 program as rapidly as possible, the Company will no longer continue with the Special Protocol Assessment process. [click link for full ...

More...

Views 25 Comments 0

Total Comments 0

Comments

Bookmarks

« Bayer's liver cancer drug approved in Europe (PharmaBiz) | High-fat diet makes mice susceptible to liver injury (News-Medical-Net) »

Currently Active Users Viewing This Article: 1 (0 members and 1 guests)

Article Tools
Show Printable Version Email this Page
Display Modes
Linear Mode Switch to Hybrid Mode Switch to Threaded Mode

Posting Rules
You may not post new threads You may post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is Off Trackbacks are On Pingbacks are On Refbacks are On Forum Rules

Forum Jump

Our Reviewed Health Care Products are sold at the following retail chains:

Disclaimer: Please be aware that it's always VERY important to read the fine print, terms and conditions, and privacy policies on our advertiser's pages. Often, many products are part of an auto-ship program that will enroll you once you purchase. If you have any questions, please contact the advertiser. We are paid to post the reviews and articles on this website and not all information is to be considered accurate. As always, please consult with a physician if you have any health concerns or questions! If you do not agree with this statement or terms and conditions, please leave this website IMMEDIATELY! Thank you/font>

All times are GMT. The time now is 08:50 AM.
Powered by vBulletin® Version 3.8.5
Copyright ©2000 - 2012, Jelsoft Enterprises Ltd.
Content Relevant URLs by vBSEO 3.2.0 All Rights Reserved. myHealthScout.com © 2006-09